Correspondence on 'prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'
Ann Rheum Dis
.
2023 Feb;82(2):e28.
doi: 10.1136/annrheumdis-2020-219377.
Epub 2020 Nov 10.
Authors
Jiyuan Shi
1
,
Ya Gao
1
,
Lili Zhang
2
,
Yang Zhao
2
,
Jianguo Xu
1
,
Jinhui Tian
3
Affiliations
1
Evidence-Based Medicine Center, Lanzhou University, Lanzhou, Gansu, China.
2
School of nursing, Southern Medical University, Guangzhou, Guangdong, China.
3
Evidence-Based Medicine Center, Lanzhou University, Lanzhou, Gansu, China 15038059737@163.com.
PMID:
33172859
DOI:
10.1136/annrheumdis-2020-219377
No abstract available
Keywords:
autoimmune diseases; epidemiology; immune system diseases.
Publication types
Meta-Analysis
Systematic Review
Letter
MeSH terms
Autoimmune Diseases*
COVID-19*
Humans
Prevalence
SARS-CoV-2